Sign inJoin waitlistJoin the waitlist

David Gandara

Senior Advisor to Director, UC Davis Comprehensive Cancer Center · University of California Davis Health

Credentials: · · · ·

History

UC Davis Comprehensive Cancer Center · University of California Davis Health
Present
Center for Experimental Therapeutics in Cancer · University of California Davis Health
Present
University of California Davis Health
Present

Newsweek Health
2013–2015
Letterman Army Medical Center
1976–1978
Internal Medicine
Madigan Army Medical Center
1973–1976
University of Texas Medical Branch at Galveston School of Medicine
1969–1973
Zoology, University of Texas, Austin TX
1965–1969

Research

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
The Lancet · 2017 · 3,995 citations
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Journal of Clinical Oncology · 2008 · Last of 20 authors · 2,675 citations
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
New England Journal of Medicine · 2005 · 1,507 citations

Primo Lara
136 papers · 3 as a fellow
KK
Karen Kelly
73 papers
DL
Derick Lau
66 papers
Jonathan Riess
41 papers
Martin Edelman
41 papers
AD
Angela Davies
40 papers
James Doroshow
39 papers
RH
Roy Herbst
38 papers
Heinz-Josef Lenz
35 papers
John Crowley
35 papers
Suresh Ramalingam
30 papers
EP
Edith Perez
28 papers

Grants

Ucdccc Nctn ug1 Program
National Cancer Institute · UG1
Contact PI · $3.7M · University of California at Davis
2019–2026
UCDCCC NCTN U10 Program
National Cancer Institute · U10
Contact PI · $3.3M · University of California at Davis
2014–2019
Southwest Oncology Group/University of California, Davis
National Cancer Institute · U10
Contact PI · $5.5M · University of California at Davis
1993–2015
Early Therapeutics Development with Phase Ii Emphasis
National Cancer Institute · N01
Contact PI · $3.1M · University Health Network
2011–2015

Clinical trials

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Principal investigator · Completed · Phase 1
University of California, Davis
2011–2017
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
University of California, Davis
2009–2011
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
SWOG Cancer Research Network
2004–2011
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
Principal investigator · Completed · Phase 3
SWOG Cancer Research Network
2002–2009